As of 11:05am ET
| -0.09 / -1.58%|
The 7 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 13.25, with a high estimate of 23.00 and a low estimate of 5.50. The median estimate represents a +136.61% increase from the last price of 5.60.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.